Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.
Ashraf S, Ashraf S, Farooq I, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Akmal R, Ghufran M, Rafique S, Akram MK, Habib Z, Siddiqui UN, Ahmad A, Arshad S, Virk MAR, Gul M, Awais AB, Hassan M, Sherazi SSH, Safdar Z, Munir I, Khalid H, Munir K, Majeed N, Alahmadi YM, Humayun A, Saboor QA, Ahmad A, Ashraf M, Izhar M; DOCTORS LOUNGE Consortium.
. Mini Rev Med Chem. 2021 Feb 19. doi: 10.2174/1389557521666210219161747. Online ahead of print.Mini Rev Med Chem. 2021.PMID: 33605857
.
.
Item in Clipboard
. Zhang X, et al.Hepatology. 2021 Sep 5. doi: 10.1002/hep.32139. Online ahead of print.Hepatology. 2021.PMID: 34482560